Lorbrexen 100 Mg (Lorlatinib) – 30 Tablets

$ 380.00

Lorbrexen 100 mg (Lorlatinib) generic Lorbrena is a prescription medication used for the treatment of metastatic non-small cell lung cancer (NSCLC) in patients with a specific abnormal type of anaplastic lymphoma kinase (ALK) gene. It is used in patients who have received alectinib, ceritinib, or both crizotinib and at least 1 other drug to treat NSCLC driven by the ALK gene.


 

Product Feature:


Manufacturer :  Everest Pharmaceuticals Ltd.
Indication :  Lung Cancer.
Generic :  Lorlatinib
Formulation :  Tablet
Pack Size :  30 Tablets
Strengths :  100 Mg
Storage :  Below 25°C
Registrations :  Export Only